BackCenter Laboratories Overview

Center Laboratories EBIT

Latest ebit for 4123.TWO: $8.7B, below the sector sector average of $2.3T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$102.41M
↓ 96.9% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

$8.71B
↑ 228.41% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Center Laboratories (4123.TWO) FAQ

The latest EBIT for 4123.TWO is $8.7B as of September 2026. That compares with $2.7B in the prior-year period — up 228.4% year over year. That is below the sector sector average of $2.3T. Investors often review this figure alongside Center Laboratories's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4123.TWO's EBIT moved from $2.7B to $8.7B — a 228.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Center Laboratories's operating scale or balance-sheet position.

Against its sector companies, 4123.TWO currently prints $8.7B for EBIT, while the sector average sits near $2.3T. That is roughly 99.6% below the sector mean. Large gaps often invite a closer look at Center Laboratories's growth, margins, and balance sheet.

A EBIT figure of $8.7B for 4123.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.3T. Explore the charts below for those layers of context.

After noting 4123.TWO's EBIT ($8.7B), review year-over-year change from $2.7B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers